Subscribe To
Biocardia (bcda) up on plans for second heart failure study
BioCardia (BCDA) completes enrollment in a pivotal phase III study on its CardiAMP cell therapy for the treatm...
October 12, 2023, 12:47 pm
Incyte (incy) posts upbeat data from phase ii vitiligo study
Incyte (INCY) announces new positive 52-week data from its mid-stage study of povorcitinib for the treatment...
October 12, 2023, 12:47 pm
Global rheumatoid arthritis market poised for us$ 1.2 billion by 2033: growing prevalence of rheumatoid arthritis boosts market growth, according to persistence market research
Key market drivers of Rheumatoid Arthritis Market: rising prevalence, increased demand for treatments, ...
October 12, 2023, 12:10 pm
Astria therapeutics strikes exclusive license agreement for dermatitis treatment portfolio
Astria Therapeutics has inked a worldwide exclusive license agreement with Ichnos Sciences for an OX40 portfolio targeting the potential ...
October 12, 2023, 9:33 am
Davita says news of ozempic's potential in treating kidney disease may have only limited impact for patients, says further studies will be needed
Dialysis company DaVita Inc. DVA, -16.86% issued a statement on Thursday in response to the news Wednesday from Novo Nordisk that its Ozempic ...
October 12, 2023, 8:43 am
Pfizer's lung cancer combination therapy approved by the fda
Pfizer Inc (NYSE:PFE) announced that the United States Food and Drug Administration (FDA) has approved BRAFTOVI (encorafenib) plus MEKTOVI (binimetin...
October 12, 2023, 8:41 am
Eli lilly stock hits new high on positive crohn's disease study results
Eli Lilly and Co (NYSE:LLY) announced on Thursday that its drug development candidate, mirikizumab, met the main goals of a late-stage study to test...
October 12, 2023, 8:35 am
Jaguar health to present october 17 at the lytham partners fall 2023 investor conference and october 18 at the bio investor forum
Top line results expected in the coming weeks for company's phase 3 OnTarget trial of crofelemer for preventative ...
October 12, 2023, 8:30 am
Fda approves pfizer's braftovi plus mektovi for a type of non-small cell lung cancer
Pfizer Inc. PFE, -0.18% said Thursday the U.S. Food and Drug Administration has approved its Braftovi plus Mektovi combination therapy as a ...
October 12, 2023, 6:56 am
Nanoviricides, inc. to present at the partnership opportunities in drug delivery conference in boston on october 16, 2023 at 6:07pm et
SHELTON, CT / ACCESSWIRE / October 12, 2023 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), announces that the Company's President, Dr. An...
October 12, 2023, 6:45 am
Y-mabs: they have earnings, but still seek the big hit
Y-mAbs Therapeutics is undervalued despite growing sales of their approved cancer therapy, presenting an opportunity for investors. Their approved pro...
October 11, 2023, 7:14 pm
Why investors punished baxter international stock today
A drug made by a rival tested well in a clinical trial for kidney disease. That treatment is currently ...
October 11, 2023, 6:49 pm
Select water solutions: an undervalued and overlooked way to play the oil sector
Select Water Solutions focuses on water infrastructure and treatment services in the oil and gas indust...
October 11, 2023, 1:56 pm
Ozempic study shakes up market for kidney and insulin treatments
American depositary receipts (ADRs) of Novo Nordisk (NOVO) jumped over 6% in early trading on Wednesday, while shares of kidney dialysis machine and i...
October 11, 2023, 1:05 pm
Conduit pharmaceuticals partners with clinconnect on cocrystal development program for azd1656
Collaboration underscores Conduit’s mission to advance promising treatments by developing assets that...
October 11, 2023, 12:30 pm
Tempest therapeutics' stock jumps 1,900% as liver-cancer treatment shows promise
Shares of Tempest Therapeutics Inc. TPST, +1942.52% soared more than 1,900% on Wednesday after the company released study results for its investigatio...
October 11, 2023, 12:29 pm
Electrocore expands intellectual property portfolio for non-invasive vagus nerve stimulation (nvns) technology
ROCKAWAY, N.J., Oct. 11, 2023 (GLOBE NEWSWIRE) — electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, t...
October 11, 2023, 12:00 pm
Patient with candida krusei infection in matinas biopharma’s oral mat2203 expanded access program achieves complete clinical resolution
BEDMINSTER, N.J., Oct. 11, 2023 (GLOBE NEWSWIRE) — Matinas BioPharma (NYSE American: MTNB), a clinical-stage biopharmaceutical company focused on de...
October 11, 2023, 11:30 am
Silk road medical stock plummets on ceo exit and revenue downgrade
Silk Road Medical (NASDAQ:SILK) stock halved in value at the start of Wednesday's trading after an after-hours profit warning. The company, which has ...
October 11, 2023, 10:58 am
Tiziana life sciences to present ms treatment at ectrims annual congress
Tiziana Life Sciences Ltd (NASDAQ:TLSA) has announced that a late breaking poster titled, "treatment Of...
October 11, 2023, 9:26 am